Auriga Downgrades Myriad Genetics (MYGN) to Hold on Valuation; Delayed Gratification
Tweet Send to a Friend
Auriga downgraded Myriad Genetics (NASDAQ: MYGN) to Hold. PT lowered from $27 to $25.
Auriga analyst says, "Myriad Genetics has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Auriga analyst says, "Myriad Genetics has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
